SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-282577
Filing Date
2023-11-24
Accepted
2023-11-24 07:30:58
Documents
2
Group Members
CHRIS HOLLOWOODROEL BULTHUISSYNCONA HOLDINGS LTDSYNCONA INVESTMENT MANAGEMENT LTDSYNCONA LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d557468dsc13da.htm SC 13D/A 136776
2 EX-99.6 d557468dex996.htm EX-99.6 7161
  Complete submission text file 0001193125-23-282577.txt   145886
Mailing Address FRANCES HOUSE, PO BOX 273 SIR WILLIAM PLACE ST PETER PORT, GUERNSEY X0 GY1 3 RD
Business Address 3RD FLOOR, ARNOLD HOUSE PO BOX 273, ST JULIAN'S AVENUE ST PETER PORT Y7 GY1 3RD 001442039817909
Syncona Portfolio Ltd (Filed by) CIK: 0001725042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 0331
Type: SC 13D/A

Mailing Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP
Business Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Subject) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91620 | Film No.: 231435013
SIC: 2836 Biological Products, (No Diagnostic Substances)